Ratner, Nancy

Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.

Brannan, C. I., Perkins, A. S., Vogel, K. S., Ratner, N., Nordlund, M. L., Reid, S. W., Buchberg, A. M., Jenkins, N. A., Parada, L. F., & Copeland, N. G. (1994) · Genes & Development

Neurofibromatosis and Schwannoma CasesNeuroblastoma Research and Treatments

Cited by 641

Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis

DeClue, J. E., Papageorge, A. G., Fletcher, J. A., Diehl, S. R., Ratner, N., Vass, W. C., & Lowy, D. R. (1992) · Cell

Neurofibromatosis and Schwannoma CasesProtein Kinase Regulation and GTPase Signaling

Cited by 580

Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone

Isfort, I., Elges, S., Cyra, M., Berthold, R., Renner, M., Mechtersheimer, G., Åman, P., Larsson, O., Ratner, N., Hafner, S., et al. (2019) · Scientific Reports

Hippo pathway signaling and YAP/TAZSarcoma Diagnosis and Treatment

Cited by 35